華勝天成(600410.SH):AI應用相關產品主要為“智能客服”、“智能數據助手”等
格隆匯11月28日丨華勝天成(600410.SH)公佈股票交易風險提示公吿,公司有關注到部分媒體對公司與華為合作以及公司AI應用產品關注度較高,現就相關事項説明如下:公司與華為主要合作模式為基於項目建設及運營需求採購華為軟硬件產品;截至2024年9月30日,公司向華為的供貨金額不足1000萬元;公司AI應用相關產品主要為“智能客服”、“智能數據助手”等,前述業務確認收入佔業務收入比例較小,對公司業績不構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.